Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

2 Tech Mid-Caps Under $10 With Big Upside: https://www.marketbeat.com/logos/articles/med_20230524082119_2-tech-mid-caps-under-10-with-big-upside.jpg
2 Tech Mid-Caps Under $10 With Big Upside

This year’s stock market can be summed up in one word — resilient.

On top of inflationary pressures and rising rates, not even government debt ceiling uncertainty has been able to slow the upward

Microbot Medical spikes 150% on its Endovascular Surgical Robot: https://www.marketbeat.com/logos/articles/med_20230523111957_chart-mbot.jpg
Microbot Medical spikes 150% on its Endovascular Surgical Robot

Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit

BJ's Pulse On Retail Beats Expectations: https://www.marketbeat.com/logos/articles/med_20230523100821_bjs-pulse-on-retail-beats-expectations.jpg
BJ's Pulse On Retail Beats Expectations

BJ's Wholesale Club (NYSE: BJ) reported its first quarter 2023 earnings results on Tuesday morning when the broader stock market index was trading lower by a quarter of a percentage point

Dick’s Sporting Goods Deserves A Higher Price Multiple: https://www.marketbeat.com/logos/articles/med_20230523091047_chart-dks-5232023.png
Doximity is an Overlooked Medical Ecosystem AI Play: https://www.marketbeat.com/logos/articles/med_20230521161256_chart-docs.jpg
Doximity is an Overlooked Medical Ecosystem AI Play

Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like a Microsoft Co. (NASDAQ: MSFT) owned

Can IonQ Be the Leader in Quantum Computing as a Service?: https://www.marketbeat.com/logos/articles/med_20230521162346_chart-ionq.jpg
Can IonQ Be the Leader in Quantum Computing as a Service?

Quantum computing has become a reality as more applications materialize. The viral growth of artificial intelligence (AI) applications driven by the AI battle between Alphabet Inc. (NASDAQ: GOOGL)

Will Dividends Take Center Stage In The Second Half Of 2023?: https://www.marketbeat.com/logos/articles/med_20230522155723_will-dividends-take-center-stage-in-the-second-hal.jpg
Will Dividends Take Center Stage In The Second Half Of 2023?

Plenty of individual stocks are notching outsized gains this year, with S&P 500 leaders Nvidia Corp. (NASDAQ: NVDA) and Meta Platforms Inc. (NASDAQ: META) more than doubling in price. Advanced

C3.ai Executes a Rope-a-Dope Attack on Sleeping Bears: https://www.marketbeat.com/logos/articles/med_20230521160925_charty-ai.jpg
C3.ai Executes a Rope-a-Dope Attack on Sleeping Bears

Enterprise artificial intelligence (AI) software provider C3.ai Inc. (NASDAQ: AI) surprised investors by raising its fiscal Q4 2023 earnings two weeks before its release. It sent shares surging

2 Tech Stocks With Upgrades and Positive Outlook: https://www.marketbeat.com/logos/articles/med_20230522104438_chart-sym-5222023.png
2 Tech Stocks With Upgrades and Positive Outlook

Symbotic (NASDAQ: SYM) and Global-e Online (NASDAQ: GLBE) are members of the 2022 class of IPOs. The 1st came to market as a reverse merger, while the other went the traditional IPO route with

All Aboard! The Sell-Side Has Railroads In Reversal: https://www.marketbeat.com/logos/articles/med_20230522093653_chart-unp-csx-5222023.png
All Aboard! The Sell-Side Has Railroads In Reversal

Growing trends within the railroad market have the stocks in reversal. The combination of institutional support and analysts’ upgrades have the stocks at a bottom and moving higher with an

Don’t Get Burned By The AI Boom: https://www.marketbeat.com/logos/articles/med_20230522083221_chart-amzn-msft-5222023.png
Don’t Get Burned By The AI Boom

AI is happening. It’s about to change the world and will cause a boom in productivity unlike any we’ve seen. The shift to AI will also cause a boom in the stock market, and investors should be

Will The Breakout in VanEck Semiconductor ETF Continue?: https://www.marketbeat.com/logos/articles/med_20230521100900_smh.jpg
Will The Breakout in VanEck Semiconductor ETF Continue?

Investors in semiconductors had a lot to smile about last week. Last week's breakout in VanEck Semiconductor ETF (NASDAQ: SMH) was nothing short of impressive. Both traders and investors would

Warren Buffett Boosts Occidental Stake, Adds 3.46 Million Shares: https://www.marketbeat.com/logos/articles/med_20230521192856_warren-buffett-boosts-occidental-stake-adds-3.jpg
Warren Buffett Boosts Occidental Stake, Adds 3.46 Million Shares

Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.B) is continuing to shop in the Occidental Petroleum Corp. (NYSE: OXY) aisle, adding 3.46 million shares to his position. The new purchases

What's Behind The Recent Meteoric Rise Of Tingo Group: https://www.marketbeat.com/logos/articles/20230521083322_tingo.png
What's Behind The Recent Meteoric Rise Of Tingo Group

Tingo Group NASD: TIO is a global fintech and agri-tech company with operations spanning multiple continents. The company operates in Africa, Southeast Asia, and the Middle East. Tingo’s wholly

Netflix Stock Just Had Its Largest Intraday Gain Since 2022: https://www.marketbeat.com/logos/articles/med_20230521155440_netflix-ratings.jpg
Netflix Stock Just Had Its Largest Intraday Gain Since 2022

Netflix (NASDAQ: NFLX)was up 7.49% last week after the company revealed that its $7 per-month ad-based plan, which the company first launched in November, has reached 5 million monthly active

Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine: https://www.irw-press.at/prcom/images/messages/2023/70633/Accesswire-Neurimmune_220523.001.jpeg
Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine

Results also presented during late-breaking session at ESC Heart Failure congress 2023

 

ZURICH, SWITZERLAND / ACCESSWIRE / May 20, 2023 / Neurimmune announced today that primary results of

Why You Should Consider Buying Nvidia Ahead Of Earnings: https://www.marketbeat.com/logos/articles/med_20230519085203_why-you-should-consider-buying-nvidia-ahead-of-ear.jpg
Why You Should Consider Buying Nvidia Ahead Of Earnings

And just like that, shares of Nvidia Corporation (NASDAQ: NVDA) are back to within a good day's worth of trading from all-time highs. About 10% to be exact, a gap which we expect to continue

Foot Locker And The Ebbing Tide Of Discretionary Spending: https://www.marketbeat.com/logos/articles/med_20230519081522_chart-fl-5192023.png
Foot Locker And The Ebbing Tide Of Discretionary Spending

Foot Locker (NYSE: FL) is down 25% after reporting a horrible quarter. Repositioning efforts impact the results, but other details overshadow them. The takeaway is that the tide of discretionary

Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?: https://www.marketbeat.com/logos/articles/med_20230518141428_is-pfizers-seagen-deal-in-jeopardy-amid-antitrust.jpg
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?

Pfizer Inc. (NYSE: PFE) continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.’s (NASDAQ: AMGN) planned acquisition of Horizon

Cisco Systems Falls Into The Buy Zone: https://www.marketbeat.com/logos/articles/med_20230518115407_chart-csco-5182023.png
Cisco Systems Falls Into The Buy Zone

Shares of Cisco Systems (NASDAQ: CSCO) fell 3% following its Q3 report sending shares into the buy zone. The drop was driven by fears centered on a slowing order book that points to sluggish

Zoetis Declares New Dividend, Hinting At Undervaluation: https://www.marketbeat.com/logos/articles/med_20230518102050_zoetis-declares-new-dividend-hinting-at-undervalua.jpg
Zoetis Declares New Dividend, Hinting At Undervaluation

Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements. Even

Good News For Walmart Isn’t So Great For Everybody Else: https://www.marketbeat.com/logos/articles/med_20230518081924_chart-wmt-5182023.png
Good News For Walmart Isn’t So Great For Everybody Else

Walmart (NYSE: WMT) had a better-than-expected quarter and raised its full-year guidance, but the news isn’t as great as it may seem. The gains were driven by isolated segments that confirm

Berry Global, The Backbone Of Consumer Packaging You Should Own: https://www.marketbeat.com/logos/articles/med_20230518073403_berry-global-the-backbone-of-consumer-packaging-yo.jpg
Berry Global, The Backbone Of Consumer Packaging You Should Own

Berry Global Group (NYSE: BERY) is one of those businesses that do not seem to let off the gas pedal, significantly when all other sectors lag in performance. As a result, Berry has been

Copart Auctions, A Little Outlet For America's Car Problems: https://www.marketbeat.com/logos/articles/med_20230518072530_copart-auctions-a-little-outlet-for-americas-car-p.jpg
Copart Auctions, A Little Outlet For America's Car Problems

Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into

Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings: https://www.marketbeat.com/logos/articles/med_20230518072749_vertex-pharmaceuticals-hits-record-high-on-strong.jpg
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report. 

Net income of $3.05 a